Past Events

CDC distribution roadmap, safety oversight plans, and other takeaways from FDA’s big COVID-19 vaccine meeting - ExBulletin
In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic.
Group Of Independent Experts To Advise FDA On Coronavirus Vaccine Approval - WUWM Milwaukee
It's up to the Food and Drug Administration to decide whether a COVID-19 vaccine is safe and effective enough for public distribution.
In historic Covid-19 adcomm, vaccine experts debate a sea of questions — but offer no clear answers - Endpoints News
The most widely anticipated and perhaps most widely watched meeting in the FDA’s 113-year history ended late Thursday night with a score of questions and very few answers.
Confidence still lacking in future COVID-19 vaccines - BioWorld
With the lack of public trust and confidence the biggest barrier to SARS-CoV-2 vaccines in the U.S., the risk of granting an emergency use authorization (EUA) to a vaccine with safety issues or questionable efficacy could
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data - PNAS
COVID-19 has swept across the world, overwhelming healthcare systems and raising countless questions about how best to diagnose patients, treat infections, save lives, and contain the pandemic.
FDA study finds fear and distrust among front-line workers and minority groups around COVID-19 vaccines - Fierce Pharma
Powerful, illuminating and sobering—that’s the description from a research group summing up its initial listening sessions with front-line workers and minority groups about a vaccine.
What to expect from the official COVID-19 vaccine committee - ABC News
As the race for an effective COVID-19 vaccine continues, the public will get inside look at one a crucial part of the Food and Drug Administration's decision-making p
October, no surprise: COVID-19 vax AdComm booked for the 22nd - RAPS
The US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee plans to meet on 22 October to discuss matters related to authorization and licensure of vaccines for COVID-19.
FDA Applauds Role of Clinical Trials in Fighting COVID-19 - The Association of Clinical Research Professionals
“Clinical trials are critical” in the battle against the global COVID-19 pandemic, Amy Abernathy, principal deputy commissioner and acting CIO of the U.S.
Remarks by Dr. Hahn to the Global Coalition for Regulatory Science Research
I’m delighted to be with you today for this important meeting of the Global Coalition for Regulatory Science Research.  I only wish that we could be together in person.